AI assistant
Sending…
VivoSim Labs, INC. — Director's Dealing 2015
Mar 16, 2015
35369_dirs_2015-03-16_abc6c42b-2eaa-47e7-bc5b-64dd4f4afc24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2015-03-12
Reporting Person: Presnell Sharon Collins (EVP, Research & Dev & CTO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-12 | Common Stock | M | 50000 | $.08 | Acquired | 74064 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-12 | Stock Option (Right to Buy) | $.08 | M | 50000 | Disposed | 2021-10-13 | Common Stock (50000) | Direct |
Footnotes
F1: Represents shares acquired pursuant to the exercise of a previously granted stock option.
F2: This number does not include 1,052,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,126,256 shares of common stock.
F3: 25% of the option shares vest and become exercisable on May 2, 2012 and the remaining shares vest in 3 equal annual installments thereafter.
More from VivoSim Labs, INC.
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 27
Interim / Quarterly Report
2026
Feb 11
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 29
Regulatory Filings
2025
Dec 18